MATHEW ABY J. (EVP & Chief Scientific Officer) sold 0.1% of their position (529.00 shares) of BIOLIFE SOLUTIONS INC on the open market
Open‑market sale worth $11.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2026ACC: 0001628280-26-015340
Officer· EVP & Chief Scientific Officer
Since Mar 2026
-529.00
Net shares
Net seller
$11.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
529.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−529.00
Price / share
$20.74
Trade value
$10.97K
% of position
0.1%
3/3/2026
393.47K→392.94K
Total
Net shares
−529.00
Net value
-$10.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2026 | S · Sale | −529.00 | $20.74 | $10.97K | 0.1% | 393.47K | 392.94K |
| Total | −529.00 | -$10.97K | ||||||
Derivative Transactions0
No derivative transactions reported